|
Delayed
Sao Paulo
11:01:00 18/08/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 81.61 BRL | -85.92% |
|
-4.21% | +4.31% |
| 13/08 | Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says | MT |
| 11/08 | Jefferies Adjusts Price Target on Vertex Pharmaceuticals to $633 From $610, Maintains Buy Rating | MT |
| Market Cap | 131B 677B 113B 106B 96.39B 181B 12,494B 184B 1,241B 486B 6,259B 491B 480B 20,822B | P/E 2026 * |
30.4x | P/E 2027 * | 24.9x |
|---|---|---|---|---|---|
| Enterprise Value | 116B 603B 101B 94.3B 85.89B 161B 11,132B 164B 1,105B 433B 5,577B 437B 428B 18,553B | EV / Sales 2026 * |
8.83x | EV / Sales 2027 * | 7.7x |
| Free-Float |
99.79% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | -85.92% | ||
| 1 week | -4.21% | ||
| Current month | +5.81% | ||
| 1 month | +5.82% | ||
| 3 months | +19.29% | ||
| 6 months | +5.73% | ||
| Current year | +4.31% |
| 1 week | 81.61 |  | 84.96 |
| 1 month | 74.56 | | 85.52 |
| Current year | 65.18 | | 86.31 |
| 1 year | 62.2 | | 86.31 |
| 3 years | 52.29 | | 93.56 |
| 5 years | 30.22 | | 93.56 |
| 10 years | 20.29 | | 93.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 01/04/2020 | |
Charles Wagner
DFI | Director of Finance/CFO | 57 | 10/04/2019 |
Sean Daughtry
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 01/01/1998 |
Jeffrey Leiden
CHM | Chairman | 70 | 01/05/2012 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 18/06/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -85.92% | -4.21% | - | - | 131B | |
| +2.29% | -0.08% | +73.91% | +122.17% | 1,055B | |
| +2.65% | +3.84% | +53.07% | +56.41% | 632B | |
| +2.49% | +2.39% | +23.96% | +70.55% | 442B | |
| +1.19% | -2.47% | +40.55% | +41.07% | 351B | |
| +1.65% | -0.30% | +25.20% | +40.37% | 290B | |
| +1.83% | -0.59% | +0.30% | +10.47% | 243B | |
| +1.09% | +2.38% | +44.95% | +62.00% | 227B | |
| +1.10% | -3.91% | -15.05% | -52.81% | 200B | |
| +2.34% | +4.10% | +19.79% | +86.27% | 172B | |
| Average | -6.97% | -1.44% | +29.63% | +48.50% | 401.39B | |
| Weighted average by Cap. | -1.03% | -1.87% | +42.71% | +67.19% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.19B 68.37B 11.39B 10.68B 9.73B 18.29B 1,261B 18.55B 125B 49.07B 632B 49.52B 48.45B 2,102B | 14.58B 75.59B 12.59B 11.81B 10.76B 20.23B 1,394B 20.51B 138B 54.26B 699B 54.76B 53.57B 2,324B |
| Net income | 4.31B 22.32B 3.72B 3.49B 3.18B 5.97B 412B 6.05B 40.88B 16.02B 206B 16.16B 15.81B 686B | 5.22B 27.04B 4.5B 4.23B 3.85B 7.24B 499B 7.34B 49.54B 19.41B 250B 19.59B 19.16B 831B |
| Net Debt | -14.24B -73.82B -12.29B -11.53B -10.51B -19.75B -1,362B -20.03B -135B -52.98B -682B -53.47B -52.31B -2,269B | -18.44B -95.57B -15.92B -14.93B -13.6B -25.57B -1,763B -25.93B -175B -68.6B -883B -69.22B -67.72B -2,938B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/08/26 | BRL 81.61 | -85.92% | 56 |
| 14/08/26 | BRL 83.28 | -1.87% | 112 |
| 12/08/26 | BRL 84.87 | -0.39% | 4 |
| 11/08/26 | BRL 85.20 | +2.49% | 901 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VRTX Stock
- VRTX34 Stock
Select your edition
All financial news and data tailored to specific country editions
